NEOPEPTINE RB DROPS

Indications

• Hypertension
• Benign prostatic hyperplasia
• Urinary retention related to prostate enlargement

Dosage

Children: Refer to the BNF for Children for appropriate dosing guidelines in the paediatric population.

Adults: Refer to the BNF for specific dosing recommendations based on individual clinical scenarios.

Mechanism of action

Alpha acts by selectively blocking alpha-1 adrenergic receptors, which are responsible for mediating vasoconstriction in blood vessels. By inhibiting these receptors, alpha promotes vasodilation, leading to a decrease in peripheral vascular resistance and subsequently lowering blood pressure. Additionally, this action can help alleviate urinary symptoms associated with an enlarged prostate.

Pharmacodynamics

The pharmacodynamics of alpha involve its competitive antagonism at alpha-1 adrenergic receptors, resulting in decreased vasoconstriction and increased blood flow. This mechanism is beneficial in conditions characterized by high blood pressure and urinary retention due to prostatic enlargement. The onset of action typically occurs within hours, with peak effects observed within a few days of consistent dosing.

Pharmacokinetics

Alpha is absorbed well from the gastrointestinal tract, with peak plasma concentrations achieved within 1-3 hours post-administration. The drug undergoes hepatic metabolism, primarily via cytochrome P450 enzymes, resulting in active and inactive metabolites. The elimination half-life varies, but it generally is around 6-12 hours, allowing for once-daily dosing in many cases. Renal excretion is a significant route for its metabolites, necessitating caution in patients with renal impairment.

Interactions

• maois, irreversible + alpha blockers: Severe (increases effects)
• ribociclib + alpha blockers: Severe (increases exposure)
• cobicistat + alpha blockers: Moderate (increases exposure)
• idelalisib + alpha blockers: Moderate (increases exposure)
• dronedarone + alpha blockers: Unknown (increases exposure)
• antifungals, azoles + alpha blockers: Unknown (increases exposure)
• crizotinib + alpha blockers: Unknown (increases exposure)
• imatinib + alpha blockers: Unknown (increases exposure)
• letermovir + alpha blockers: Unknown (increases exposure)
• clarithromycin + alpha blockers: Unknown (increases exposure)

Indications

• Digestive disorders
• Dyspepsia
• Indigestion
• Protein malabsorption
• Carbohydrate malabsorption

Dosage

Children: Refer to specific product guidelines or consult a healthcare professional for appropriate dosing.

Adults: Refer to specific product guidelines or consult a healthcare professional for appropriate dosing.

Mechanism of action

Amylase catalyzes the hydrolysis of starch into sugars, facilitating carbohydrate digestion. Papain breaks down proteins into peptides and amino acids, enhancing protein digestion. Dill may contribute by reducing gas and bloating, thus improving overall digestive comfort. The combined action of these components improves the digestive process and may alleviate symptoms associated with indigestion.

Pharmacodynamics

The pharmacodynamics of amylasepapainedill involve the synergistic effects of its components on digestion. Amylase acts on carbohydrates, papain on proteins, and dill may have a soothing effect on the gastrointestinal tract. This combination can enhance nutrient absorption, reduce gastrointestinal discomfort, and improve overall digestive health.

Pharmacokinetics

The pharmacokinetics of digestive enzymes like amylase and papain are generally characterized by their local action in the gastrointestinal tract, where they exert their effects without significant systemic absorption. The enzymes are typically active in the lumen of the intestine, and their activity is influenced by factors such as pH and the presence of food. The duration of action depends on digestive transit time and the presence of substrates for the enzymes.

Pregnancy

There is limited data on the use of amylase, papain, and dill during pregnancy. Caution is advised.

Breast-feeding

There is insufficient information on the excretion of amylase, papain, and dill in human milk. Use with caution while breastfeeding.

Storage

Store at room temperature, away from moisture and direct sunlight. Keep out of reach of children.

Indications

• Digestive discomfort
• Bloating
• Gas
• Respiratory conditions
• Cough
• Infections (antimicrobial use)

Dosage

Adults: For adults, oilanise is typically used in doses of 1-2 drops of anise oil in a carrier oil or as directed by a healthcare provider. It is often used in a culinary

Mechanism of action

The active compounds in anise oil, primarily anethole, exert their effects through several mechanisms. Anethole acts as a modulator of the GABAergic system, promoting relaxation and potentially contributing to its sedative effects. It also exhibits antispasmodic effects on the gastrointestinal tract, which helps alleviate symptoms of bloating and gas. Furthermore, the antimicrobial properties of anise oil are attributed to its ability to disrupt the cell membranes of certain bacteria and fungi, inhibiting their growth.

Pharmacodynamics

Oilanise's pharmacodynamics involve its interaction with various receptors and pathways in the body. The oil's antispasmodic action helps to relax smooth muscle in the intestines, reducing cramping and discomfort. Its expectorant properties assist in loosening mucus in the respiratory tract, facilitating easier breathing. The anti-inflammatory effects may also aid in reducing inflammation in respiratory conditions, while its antimicrobial properties help combat infections.

Pharmacokinetics

Oilanise is typically administered via inhalation or oral consumption, with absorption occurring in the gastrointestinal tract or through the respiratory mucosa. The active compounds, such as anethole, are metabolized primarily in the liver and may undergo conjugation with glucuronic acid. The elimination half-life of anethole is variable, depending on the route of administration and individual metabolism. The oil is generally excreted via urine and feces, with a small percentage remaining unchanged.

Pregnancy

Oilanise should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. Consult a healthcare professional.

Breast-feeding

There is limited data on the excretion of oilanise in human milk. Caution should be exercised when administering to nursing mothers.

Storage

Store in a cool, dry place away from direct sunlight. Keep out of reach of children.

Indications

• Digestive disorders
• Bloating
• Gas
• Indigestion
• Carminative remedy

Dosage

Children: Refer to appropriate herbal and essential oil dosing guidelines for children, as specific doses may vary and should be determined based on age and weight.

Adults: Refer to appropriate herbal and essential oil dosing guidelines, as specific doses may vary based on formulation and intended use.

Mechanism of action

The primary constituents of oilcaraway, particularly carvone and limonene, exert their effects through multiple mechanisms. Carvone acts as a carminative by relaxing the smooth muscles of the gastrointestinal tract, thereby reducing bloating and gas. Additionally, its antimicrobial properties help inhibit the growth of certain bacteria, contributing to a balanced gut microbiota. Limonene has anti-inflammatory properties that may aid in reducing gastrointestinal inflammation.

Pharmacodynamics

Oilcaraway exhibits carminative effects, which help relieve discomfort associated with gas and bloating. Its antimicrobial properties may assist in maintaining gastrointestinal health by preventing the overgrowth of pathogenic bacteria. The anti-inflammatory effects of limonene can contribute to the overall soothing effect on the digestive tract, promoting digestive comfort and health.

Pharmacokinetics

The absorption of oilcaraway and its active constituents occurs through the gastrointestinal tract after oral administration. Metabolism primarily takes place in the liver, where compounds like carvone undergo oxidation. The elimination of these compounds is facilitated by renal excretion, with the half-life varying depending on individual metabolic rates and dosage. However, specific pharmacokinetic parameters for oilcaraway are not well-documented, necessitating further research.

Adverse effects

• Allergic reactions
• Gastrointestinal discomfort
• Nausea
• Vomiting

Precautions

• Use with caution in individuals with known allergies to caraway or related plants
• Should be used under medical supervision in pregnant or breastfeeding women

Pregnancy

Oilcaraway is generally not recommended during pregnancy due to insufficient safety data.

Breast-feeding

Limited data available; consult a healthcare provider before use.

Storage

Store in a cool, dry place away from direct sunlight.

Formulations

• Essential oil
• Herbal extracts